Skip to main content

Table 4 Prevalent and incident use of psychotropic medicines during the perinatal period

From: Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance

N = 343,299 Prevalent use in pregnancy Prevalent use in pregnancy; > 1 Rx* Incident use in pregnancy Incident use in pregnancy > 1 Rx* Incident use postpartum
Antidepressants 15253 (4.4) 11588 (3.4) 7,022 (2.1) 5353 (1.6) 15652 (4.6)
 SSRI 10998 (3.2) 8300 (2.4) 6,416 (1.9) 5079 (1.5) 14625 (4.3)
Anxiolytics 4574 (1.3) 2992 (0.9) 9961 (2.9) 7100 (2.1) 7583 (2.2)
 Benzo** 4271 (1.2) 2742 (0.8) 9,215 (2.7) 6657 (1.9) 7319 (2.1)
Antipsychotic 559 (0.2) 365 (0.1) 1814 (0.5) 854 (0.3) 773 (0.2)
 Typical antipsychotic 27 (0.01) 14 (0.00) 1546 (0.5) 698 (0.2) 326 (0.1)
 Atypical antipsychotic 480 (0.1) 307 (0.09) 262 (0.1) 158 (0.05) 447 (0.1)
ADHD 1741 (0.5) 886 (0.3) 321 (0.1) 135 (0.04) 604 (0.2)
  1. *Removes women who only filled one prescription in the first trimester.
  2. **benzodiazepine or benzodiazepine like product.